CLP257
|
|
- CAS-Nr.
- 1181081-71-9
- Englisch Name:
- CLP257
- Synonyma:
- CLP257;(Z)-5-(4-fluoro-2-hydroxybenzylidene)-2-(tetrahydropyridazin-1(2H)-yl)thiazol-4(5H)-one;(5Z)-5-[(4-Fluoro-2-hydroxyphenyl)methylene]-2-(tetrahydro-1-(2H)-pyridazinyl)-4(5H)-thiazolone;4(5H)-Thiazolone, 5-[(4-fluoro-2-hydroxyphenyl)methylene]-2-(tetrahydro-1(2H)-pyridazinyl)-, (5Z)-;Inhibitor,post-translationally,hypersensitivity,plasma,Potassium Channel,neuropathic,antihyperalgesic,CLP 257,membrane,KcsA,mechanical,sensitivity,CLP-257,CLP257,KCC2,inhibit
- CBNumber:
- CB94667761
- Summenformel:
- C14H14FN3O2S
- Molgewicht:
- 307.34
- MOL-Datei:
- 1181081-71-9.mol
|
CLP257 Eigenschaften
- Siedepunkt:
- 473.3±55.0 °C(Predicted)
- Dichte
- 1.50±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C
- L?slichkeit
- DMSO: 20 mg/ml
- pka
- 7.23±0.40(Predicted)
- Aggregatzustand
- powder
- Farbe
- white to yellow to light brown
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
|
Sicherheit |
|
CLP257 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
CLP257 has been used as a K
+- Cl
- cotransporter 2 (KCC2) enhancer in human neuron culture.
Biochem/physiol Actions
CLP257 is a selective K+-Cl? cotransporter KCC2 activator that restored impaired Cl? transport in neurons with reduced KCC2 activity. Apparently, CLP257 modulates plasmalemmal KCC2 protein turnover post-translationally.
CLP257 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
CLP257 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 28)Lieferanten
- (5Z)-5-[(4-Fluoro-2-hydroxyphenyl)methylene]-2-(tetrahydro-1-(2H)-pyridazinyl)-4(5H)-thiazolone
- CLP257
- 4(5H)-Thiazolone, 5-[(4-fluoro-2-hydroxyphenyl)methylene]-2-(tetrahydro-1(2H)-pyridazinyl)-, (5Z)-
- Inhibitor,post-translationally,hypersensitivity,plasma,Potassium Channel,neuropathic,antihyperalgesic,CLP 257,membrane,KcsA,mechanical,sensitivity,CLP-257,CLP257,KCC2,inhibit
- (Z)-5-(4-fluoro-2-hydroxybenzylidene)-2-(tetrahydropyridazin-1(2H)-yl)thiazol-4(5H)-one
- 1181081-71-9